Learn more

GUANGXI WUZHOU PHARM GROUP CO

Overview
  • Total Patents
    94
  • GoodIP Patent Rank
    33,408
  • Filing trend
    ⇧ 466.0%
About

GUANGXI WUZHOU PHARM GROUP CO has a total of 94 patent applications. It increased the IP activity by 466.0%. Its first patent ever was published in 2010. It filed its patents most often in China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are KHAMAR BAKULESH MAFATLAL, DEFIANTE FARMACEUTICA SA and TOXIMED GMBH.

Patent filings in countries

World map showing GUANGXI WUZHOU PHARM GROUP COs patent filings in countries
# Country Total Patents
#1 China 94

Patent filings per year

Chart showing GUANGXI WUZHOU PHARM GROUP COs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zhang Xuyan 43
#2 Liu Guanping 41
#3 Lin Yanying 35
#4 Zheng Zhiyuan 34
#5 Xian Minghua 19
#6 Huang Yusheng 18
#7 Zhong Jiemin 17
#8 Lai Shusheng 15
#9 Wu Saichun 12
#10 Chen Huanzhan 12

Latest patents

Publication Filing date Title
CN110894494A Method for large-scale high-density suspension culture of 293 cell high-yield adenovirus
CN109927949A A kind of filling delivery system of full-automatic ingredient and method
CN109821794A Freeze dryer circulating cleaning equipment
CN109879030A Freeze-drying prods automatic assembly line
CN109867105A It is a kind of to realize supermatic aluminium lid blanking device
CN109932071A A kind of device for fixing xeothermic detection probe
CN109893674A Disinfection system and its sterilizing methods applied to freeze-drying cabinet
CN109867116A Freeze-drying prods automatic feed/discharge system
CN109882710A A kind of four-way wind speed measuring apparatus and method
CN110833547A Use of pyrazolopyrimidine derivatives for the treatment of rheumatoid arthritis
CN110833558A Use of pyrazolopyrimidine derivatives for the treatment of diabetic nephropathy
CN110835344A Use of pyrazolopyrimidine derivatives for the treatment of myocarditis
CN110833550A Application of pyrazolopyrimidine derivative in treatment of liver injury caused by acute pancreatitis
CN110833554A Use of pyrazolopyrimidine derivatives for the treatment of autoimmune thyroid disorders
CN110833553A Use of pyrazolopyrimidine derivatives for the treatment of Arthus response
CN110833555A Use of pyrazolopyrimidine derivatives for the treatment of ulcerative colitis
CN110833549A Use of pyrazolopyrimidine derivatives in the treatment of chronic pelvic inflammatory disease
CN110833556A Use of pyrazolopyrimidine derivatives for the treatment of hepatic fibrosis
CN110833551A Use of pyrazolopyrimidine derivatives for the treatment of acute pancreatitis
CN110833557A Use of pyrazolopyrimidine derivatives for the treatment of tubular nephritis